Literature DB >> 2316520

Mental retardation in heterozygotes for the fragile-X mutation: evidence in favor of an X inactivation-dependent effect.

M Rocchi1, N Archidiacono, A Rinaldi, G Filippi, G Bartolucci, G S Fancello, M Siniscalco.   

Abstract

The still debated question of whether the expression of mental retardation in heterozygous carriers of the Martin-Bell syndrome is influenced by X inactivation has been investigated in a group of phase-known double heterozygotes for the FRA-X mutant and the G6PD Mediterranean variant. In these individuals, the number of somatic cells (fibroblasts or red cells) with an active FRA-X chromosome could be assessed through the G6PD phenotype at the single-cell level. The data reported indicate a significant inverse correlation between the IQ level (as measured by the Wechsler-Bellevue test) and the percentage of fibroblast cells with an FRA-X active chromosome. In contrast, no significant correlation was found when the IQ level and red cell data were compared, thus suggesting the occurrence of somatic selection against hematopoietic stem cells with an active FRA-X chromosome.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2316520      PMCID: PMC1683671     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  29 in total

1.  Variability of red cell phenotypes between and within individuals in an unbiased sample of 77 heterozygotes for G6PD deficiency in Sardinia.

Authors:  A Rinaldi; G Filippi; M Siniscalco
Journal:  Am J Hum Genet       Date:  1976-09       Impact factor: 11.025

2.  Linkage studies of X-linked mental retardation: high frequency of recombination in the telomeric region of the human X chromosome (fragile site/linkage/recombination/X chromosome).

Authors:  K E Davies; M G Mattei; J F Mattei; H Veenema; S McGlade; K Harper; N Tommerup; K B Nielsen; M Mikkelsen; P Beighton
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

3.  Replication status of fragile X(q27.3) in 13 female heterozygotes.

Authors:  E Tuckerman; T Webb; A Thake
Journal:  J Med Genet       Date:  1986-10       Impact factor: 6.318

4.  A tetrazolium method for distinguishing between cultured human fibroblasts having eiter normal or deficient levels of glucose-6-phosphate dehydrogenase.

Authors:  A Wajntal; R DeMars
Journal:  Biochem Genet       Date:  1967-06       Impact factor: 1.890

5.  The marker (X) syndrome: a cytogenetic and genetic analysis.

Authors:  S L Sherman; N E Morton; P A Jacobs; G Turner
Journal:  Ann Hum Genet       Date:  1984-01       Impact factor: 1.670

6.  Deleted X chromosomes in patients with the fragile X syndrome.

Authors:  M Fitchett; M Seabright
Journal:  J Med Genet       Date:  1984-10       Impact factor: 6.318

7.  Heterozygous female carriers of the marker-X-chromosome: IQ estimation and replication status of fra(X)(q).

Authors:  J Paul; U Froster-Iskenius; W Moje; E Schwinger
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

8.  Additional evidence for fragile X activity in heterozygous carriers.

Authors:  I A Uchida; V C Freeman; H Jamro; M W Partington; H C Soltan
Journal:  Am J Hum Genet       Date:  1983-09       Impact factor: 11.025

9.  Inactivation pattern of the fragile X in heterozygous carriers.

Authors:  J P Fryns; A Kleczkowska; E Kubień; P Petit; H Van den Berghe
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

10.  Carrier detection and X-inactivation studies in the fragile X syndrome. Cytogenetic studies in 63 obligate and potential carriers of the fragile X.

Authors:  K B Nielsen; N Tommerup; H Poulsen; P Jacobsen; B Beck; M Mikkelsen
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

View more
  4 in total

1.  Replication patterns of the fragile X in heterozygous carriers: analysis by a BrdUrd antibody method.

Authors:  H Ohashi; A Kuwano; M Tsukahara; T Arinami; T Kajii
Journal:  Am J Hum Genet       Date:  1990-12       Impact factor: 11.025

Review 2.  The fragile X: progress toward solving the puzzle.

Authors:  W T Brown
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

3.  Fragile-X: neuropsychological test performance, CGG triplet repeat lengths, and hippocampal volumes.

Authors:  P Jäkälä; T Hänninen; M Ryynänen; M Laakso; K Partanen; A Mannermaa; H Soininen
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

4.  Generation of Isogenic Controls for In Vitro Disease Modelling of X-Chromosomal Disorders.

Authors:  Lisa Hinz; Stephanie D Hoekstra; Kyoko Watanabe; Danielle Posthuma; Vivi M Heine
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.